{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:14:50Z","timestamp":1768914890898,"version":"3.49.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-valvular atrial fibrillation (NVAF) significantly increases ischemic stroke and systemic embolism (SE) risks. Despite the proven efficacy of oral anticoagulants (OAC) in reducing these risks, their underutilization highlights a gap in clinical practice. This study examined OAC utilization patterns within the first year after NVAF diagnosis in patients without prior OAC use and the association between the timing of OAC initiation and the risk of all-cause and stroke\/SE-specific hospitalizations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study was conducted using data from the Premier Healthcare Database and linked claims from 1\/1\/2017\u20133\/31\/2021. Patients newly diagnosed with NVAF, without prior OAC use, were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 23,148 adults with newly diagnosed NVAF, 11,059 (47.8%) initiated OAC within one year. OAC users predominantly had cardiovascular disease and risk factors, whereas non-OAC users had higher rates of malignancy and dementia. Early OAC initiation (74.9% during the index visit) was linked to lower hospitalization risks compared to those initiating later (29.2% vs. 45.9% for all-cause, <jats:italic>p-value<\/jats:italic>\u2009&amp;lt;\u20090.001 and 1.3% vs. 2.6% for stroke\/SE-specific, <jats:italic>p-value<\/jats:italic>\u2009&amp;lt;\u20090.001). Adjusted odds ratios for all-cause and stroke\/SE hospitalization favored early initiation were 0.35 (95% CI: 0.32\u20130.39) and 0.34 (95% CI: 0.24\u20130.47), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study highlights OAC underutilization in NVAF patients and suggests early initiation may lower hospitalization rates. The findings emphasize the need for further research into real-world compliance with OAC guidelines and call for further research to confirm the benefits of early initiation. Personalized management strategies that consider individual patient profiles are recommended.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1522154","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:35:23Z","timestamp":1743766523000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral anticoagulant timing and hospitalization in newly diagnosed nonvalvular atrial fibrillation patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Chendi","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Curry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning An","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jdmv.2020.01.153","article-title":"Ischemic stroke and non-valvular atrial fibrillation: when to introduce anticoagulant therapy?","volume":"45","author":"Boursier-Bossy","year":"2020","journal-title":"J Med Vasc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/07853890.2018.1460489","article-title":"Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice","volume":"50","author":"Li","year":"2018","journal-title":"Ann Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.23736\/S0026-4725.17.04553-4","article-title":"Direct oral anticoagulants use in elderly patients with non valvular atrial fibrillation: state of evidence","volume":"66","author":"Benedetti","year":"2018","journal-title":"Minerva Cardioangiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/106002809703101012","article-title":"Primary stroke prevention in nonvalvular atrial fibrillation: implementing the clinical trial findings","volume":"31","author":"Howard","year":"1997","journal-title":"Ann Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2125.2004.02086.x","article-title":"Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study","volume":"57","author":"Deplanque","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000091546","article-title":"Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge","volume":"21","author":"Deplanque","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association\/American stroke association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2242964","DOI":"10.1001\/jamanetworkopen.2022.42964","article-title":"Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010\u20132020","volume":"5","author":"Ko","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10840-022-01274-1","article-title":"Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States medicare database","volume":"66","author":"Munir","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e026723","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436\u2009864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.3390\/jcm11174981","article-title":"Early anticoagulation in patients with acute ischemic stroke due to atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Palaiodimou","year":"2022","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","article-title":"Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study","volume":"90","author":"Wilson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/23969873241251931","article-title":"Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: a systematic review and meta-analysis","volume":"9","author":"Palaiodimou","year":"2024","journal-title":"Eur Stroke J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jama.2017.14586","article-title":"Association of robotic-assisted vs laparoscopic radical nephrectomy with perioperative outcomes and health care costs, 2003 to 2015","volume":"318","author":"Jeong","year":"2017","journal-title":"Jama"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1001\/jama.2020.20323","article-title":"Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations","volume":"324","author":"Kadri","year":"2020","journal-title":"Jama"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/cid\/ciab830","article-title":"Is coronavirus disease 2019 (COVID-19) less deadly now? Trends in in-hospital mortality among hospitalized COVID-19 patients in the United States","volume":"74","author":"Moon","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJMoa0707571","article-title":"Aprotinin during coronary-artery bypass grafting and risk of death","volume":"358","author":"Schneeweiss","year":"2008","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e021227","DOI":"10.1161\/JAHA.121.021227","article-title":"Claims-based score for the prediction of bleeding in a contemporary cohort of patients receiving oral anticoagulation for venous thromboembolism","volume":"10","author":"Alonso","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"key":"B26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"B28","volume-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.hroo.2024.04.005","article-title":"A targeted educational intervention increases oral anticoagulation rates in high-risk atrial fibrillation patients","volume":"5","author":"Dutta","year":"2024","journal-title":"Heart Rhythm O2"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.3390\/jcm12196182","article-title":"Oral anticoagulant use in patients with atrial fibrillation at low risk of stroke and associated bleeding complications","volume":"12","author":"Kefale","year":"2023","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e003476","DOI":"10.1161\/CIRCOUTCOMES.116.003476","article-title":"Contemporary trends in oral anticoagulant prescription in atrial fibrillation patients at low to moderate risk of stroke after guideline-recommended change in use of the CHADS(2) to the CHA(2)DS(2)-VASc score for thromboembolic risk assessment: analysis from the national cardiovascular data registry\u2019s outpatient practice innovation and clinical excellence atrial fibrillation registry","volume":"10","author":"Katz","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jacep.2019.07.011","article-title":"Ischemic and bleeding outcomes in patients with atrial fibrillation and contraindications to oral anticoagulation","volume":"5","author":"Steinberg","year":"2019","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1522154\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:35:35Z","timestamp":1743766535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1522154\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2025.1522154"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1522154","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1522154"}}